Down syndrome critical region 1 positively correlates with angiogenesis in hypopharyngeal cancer

Lv,Chao; Liu,Dayu; Wei,Xiaona

doi:10.3892/mmr.2016.5989

Down syndrome critical region 1 positively correlates with angiogenesis in hypopharyngeal cancer

Authors:
- Chao Lv
- Dayu Liu
- Xiaona Wei
View Affiliations

Affiliations: Department of Otorhinolaryngology, Yantaishan Hospital, Yantai, Shandong 264000, P.R. China, Department of Otorhinolaryngology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: December 6, 2016 https://doi.org/10.3892/mmr.2016.5989
Pages: 263-270

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypopharyngeal carcinoma has one of the highest mortality rates of head and neck cancer, therefore, the identification of markers associated with the pathogenesis and development of hypopharyngeal cancer is critical. Down syndrome critical region 1 (DSCR1) is associated with carcinogenesis and tumor growth in several types of malignancy. Activation of the vascular endothelial growth factor (VEGF) signaling pathway upregulates DSCR1. The aims of the present study were to determine the expression levels of DSCR1 and VEGF‑C in hypopharyngeal cancer, and investigate the association between DSCR1 and angiogenesis in the disease. Tissue samples from 94 cases of pathologically confirmed hypopharyngeal squamous cell carcinoma were collected. The mRNA levels of DSCR1 and VEGF‑C in cancerous and paracancerous tissues were examined using semi‑quantitative reverse transcription‑polymerase chain reaction. Microvessel density (MVD) was counted, according to the number of cluster of differentiation 34‑positive cells. Spearman's correlation analysis was utilized to analyze the association between DSCR1 and angiogenesis. The relative mRNA expression levels of DSCR1 and VEGF‑C, and the MVD were significantly increased in the cancerous tissue samples from the patients with hypopharyngeal cancer, compared with the paracancerous tissue samples from these patients. Higher levels of DSCR1 and increased MVD were associated with poorly differentiated tumors and lymph node metastasis. The mRNA expression levels of DSCR1 were positively correlated with the mRNA levels of VEGF‑C in the cancerous tissues. The protein expression levels of DSCR1 were also positively correlated with MVD in the cancerous tissues. The results indicated that DSCR1 is involved in tumor angiogenesis in patients with hypopharyngeal cancer, and is closely associated with the progression of the disease.

View Figures

View References

1	Newman JR, Connolly TM, Illing EA, Kilgore ML, Locher JL and Carroll WR: Survival trends in Hypopharyngeal cancer: A population-based review. Laryngoscope. 125:624–629. 2015. View Article : Google Scholar : PubMed/NCBI
2	Berrino F and Gatta G: Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE working group. Eur J Cancer. 34:2154–2161. 1998. View Article : Google Scholar : PubMed/NCBI
3	Li X, Liu X, Wang J, Wang Z, Jiang W, Reed E, Zhang Y, Liu Y and Li QQ: Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells. Anticancer Res. 23:2481–2487. 2003.PubMed/NCBI
4	Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995. View Article : Google Scholar : PubMed/NCBI
5	Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
6	Ferrara N: VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
7	Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med. 9:669–676. 2003. View Article : Google Scholar : PubMed/NCBI
8	Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC and Kuo ML: The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer. 96:541–545. 2007. View Article : Google Scholar : PubMed/NCBI
9	Plate K: From angiogenesis to lymphangiogenesis. Nat Med. 7:151–152. 2001. View Article : Google Scholar : PubMed/NCBI
10	Olsson AK, Dimberg A, Kreuger J and Claesson-Welsh L: VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
11	Fuentes JJ, Genescà L, Kingsbury TJ, Cunningham KW, Pérez-Riba M, Estivill X and de la Luna S: DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet. 9:1681–1690. 2000. View Article : Google Scholar : PubMed/NCBI
12	Harris CD, Ermak G and Davies KJ: Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci. 62:2477–2486. 2005. View Article : Google Scholar : PubMed/NCBI
13	Hesser BA, Liang XH, Camenisch G, Yang S, Lewin DA, Scheller R, Ferrara N and Gerber HP: Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood. 104:149–158. 2004. View Article : Google Scholar : PubMed/NCBI
14	Aynaci FM, Orhan F, Celep F and Karagüzel A: Frequency of cardiovascular and gastrointestinal malformations, leukemia and hypothyroidism in children with Down syndrome in Trabzon, Turkey. Turk J Pediatr. 40:103–109. 1998.PubMed/NCBI
15	Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R and Williams RS: A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem. 275:8719–8725. 2000. View Article : Google Scholar : PubMed/NCBI
16	Vega RB, Rothermel BA, Weinheimer CJ, Kovacs A, Naseem RH, Bassel-Duby R, Williams RS and Olson EN: Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci USA. 100:669–674. 2003. View Article : Google Scholar : PubMed/NCBI
17	Iizuka M, Abe M, Shiiba K, Sasaki I and Sato Y: Down syndrome candidate region 1, a downstream target of VEGF, participates in endothelial cell migration and angiogenesis. J Vasc Res. 41:334–344. 2004. View Article : Google Scholar : PubMed/NCBI
18	Yao YG and Duh EJ: VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: A mechanism for feedback regulation of angiogenesis? Biochem Biophys Res Commun. 321:648–656. 2004. View Article : Google Scholar : PubMed/NCBI
19	Suzuki K, Nishimi D, Yagishita T, Takanami M and Hiruta N: Testicular tumor in Down syndrome. Int J Urol. 12:925–927. 2005. View Article : Google Scholar : PubMed/NCBI
20	Satgé D, Sommelet D, Geneix A, Nishi M, Malet P and Vekemans M: A tumor profile in Down syndrome. Am J Med Genet. 78:207–216. 1998. View Article : Google Scholar : PubMed/NCBI
21	Patja K, Pukkala E, Sund R, Iivanainen M and Kaski M: Cancer incidence of persons with Down syndrome in Finland: A population-based study. Int J Cancer. 118:1769–1772. 2006. View Article : Google Scholar : PubMed/NCBI
22	Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, et al: Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature. 459:1126–1130. 2009. View Article : Google Scholar : PubMed/NCBI
23	Sussan TE, Yang A, Li F, Ostrowski MC and Reeves RH: Trisomy represses Apc (Min)-mediated tumours in mouse models of Down's syndrome. Nature. 451:73–75. 2008. View Article : Google Scholar : PubMed/NCBI
24	Lu C, Pan X, Gao J and Li Z: Study of expression and significance of DSCR1 gene in laryngopharynx cancer and peri-cancerous tissues. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 25:848–850. 2011.(In Chinese). PubMed/NCBI
25	Liu D, Jia H, Holmes DI, Stannard A and Zachary I: Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1 and Nor1. Arterioscler Thromb Vasc Biol. 23:2002–2007. 2003. View Article : Google Scholar : PubMed/NCBI
26	Abe M and Sato Y: CDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis. 4:289–298. 2001. View Article : Google Scholar : PubMed/NCBI
27	World Medical Association: World Medical Association Declaration of Helsinki, . Ethical principles for medical research involving human subjects. JAMA. 310:2191–2194. 2013. View Article : Google Scholar : PubMed/NCBI
28	Sobin L and Wittekind C: UICC TNM classification of malignant tumours. 5th. Wiley Liss; New York, NY: pp. 1381997
29	Ryeom S, Baek KH, Rioth MJ, Lynch RC, Zaslavsky A, Birsner A, Yoon SS and McKeon F: Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell. 13:420–431. 2008. View Article : Google Scholar : PubMed/NCBI
30	Bunone G, Vigneri P, Mariani L, Butó S, Collini P, Pilotti S, Pierotti MA and Bongarzone I: Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol. 155:1967–1976. 1999. View Article : Google Scholar : PubMed/NCBI
31	Yonemura Y, Fushida S, Bando E, Kinoshita K, Miwa K, Endo Y, Sugiyama K, Partanen T, Yamamoto H and Sasaki T: Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer. 37:918–923. 2001. View Article : Google Scholar : PubMed/NCBI
32	Pan MG, Xiong Y and Chen F: NFAT gene family in inflammation and cancer. Curr Mol Med. 13:543–554. 2013. View Article : Google Scholar : PubMed/NCBI
33	Kroll J and Waltenberger J: The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem. 272:32521–32527. 1997. View Article : Google Scholar : PubMed/NCBI
34	Rousseau S, Houle F, Landry J and Huot J: p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15:2169–2177. 1997. View Article : Google Scholar : PubMed/NCBI
35	Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V and Ferrara N: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem. 273:30336–30343. 1998. View Article : Google Scholar : PubMed/NCBI
36	Takahashi T, Ueno H and Shibuya M: VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene. 18:2221–2230. 1999. View Article : Google Scholar : PubMed/NCBI
37	Kingsbury TJ and Cunningham KW: A conserved family of calcineurin regulators. Genes Dev. 14:1595–1604. 2000.PubMed/NCBI
38	Chan B, Greenan G, McKeon F and Ellenberger T: Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc Natl Acad Sci USA. 102:13075–13080. 2005. View Article : Google Scholar : PubMed/NCBI
39	Pinchai N, Perfect BZ, Juvvadi PR, Fortwendel JR, Cramer RA Jr, Asfaw YG, Heitman J, Perfect JR and Steinbach WJ: Aspergillus fumigatus calcipressin CbpA is involved in hyphal growth and calcium homeostasis. Eukaryot Cell. 8:511–519. 2009. View Article : Google Scholar : PubMed/NCBI